SYNTHESIS AND EVALUATION OF A MONOCATIONIC COPPER(II) RADIOPHARMACEUTICAL DERIVED FROM DYLMETHYL)-N'-(SALICYLALDIMINO)-1,3-PROPANEDIAMINE

Citation
M. Sriaran et al., SYNTHESIS AND EVALUATION OF A MONOCATIONIC COPPER(II) RADIOPHARMACEUTICAL DERIVED FROM DYLMETHYL)-N'-(SALICYLALDIMINO)-1,3-PROPANEDIAMINE, Nuclear medicine and biology, 25(2), 1998, pp. 107-110
Citations number
32
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
09698051
Volume
25
Issue
2
Year of publication
1998
Pages
107 - 110
Database
ISI
SICI code
0969-8051(1998)25:2<107:SAEOAM>2.0.ZU;2-X
Abstract
The monocationic Cu-67 complex of dylmethyl)-N'-(salicylaldimino)-1,3- propanediamine was obtained in high radiochemical purity by reaction o f Cu-67(2+) With the ligand in ethanol solution. Although this compoun d exhibited low heart uptake, the desired myocardial retention was obs erved over the 30 min time period studied in a rat model. Since the oc tanol/water partition coefficient of methyl)-N'-(salicylaldiminato)-1, 3-propanediamine] is lower than a value believed to be the optimal myo cardial uptake, it is likely that derivatives of this compound with a higher lipophilicity merit further investigation for use in myocardial imaging with copper radioisotopes. (C) 1998 Elsevier Science Inc.